3-D Matrix Ltd. engages in the research, development, manufacture, and sale of medical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 114 full-time employees. The company went IPO on 2011-10-24. The firm has Medical Product segment. The segment consists of two divisions. The medical product development and sales division is engaged in the research and development of medical equipment and drugs for surgery area, regeneration medicine area and drug delivery system (DDS) area based on the self-organizing peptide technology, including hemostatic, vascular embolization and alveolar bone reconstruction materials, among others. The research reagents sales division is engaged in the sale of medical products based on the self-organizing peptide technology for research and test use in universities and research institutes.
Follow-Up Questions
DMTRF の株価パフォーマンスは？
DMTRF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
3-D Matrix Ltd の主な事業テーマや業界は？
3-D Matrix Ltd は Biotechnology 業界、セクターは Health Care に属しています。
